Meng-Huang Wu

CEO, TMU Biodesign
Taipei Medical University Hospital/Taipei Medical University
​



Meng-Huang Wu (Max) is the director of the Prospective Innovation Center at Taipei Medical University Hospital that coordinates innovative initiatives and CEO of Taipei Medical University Biodesign. Max focuses on MedTech innovations and received training in the 2020 Stanford Global Faculty In Training program. Max was in the founding faculty of the Biodesign training program at Taipei Medical University in 2020 and led his team to win first place in the national innovation entrepreneurship competition in 2020. He is also a mentor for 500 startups, BE Capital and TMU Biomed Accelerator, that help startups initiate clinical trials in Taiwan. He is a co-host teacher for Biodesign classes at the Artificial Intelligence Medical Research Center and Innovation-Entrepreneur Center, Taipei Medical University.
 
As an active medical device clinical trial investigator, Max is a committee member of Taipei Medical University's Joint Institutional Review Board and a seed coordinator for the medical device clinical trial of Taiwan Food and Drug Administration after his training at the Rothman Institute in Philadelphia in 2013. He is also the director of spine division, department of orthopedics at Taipei Medical University Hospital, board director of Taiwan Society of Endoscopic Spine Surgery, Taiwan Society of Minimally Invasive Spine Surgery, Taiwan Medical Design Society, and PhD in Clinical Medical Sciences of Chang-Gung University that experts in bone regeneration, biomaterials, and spinal disorders. He has 71 publications, 2 book chapters, and 9 issued patents. He has collaborated with Industry Technology Research Institution and developed several innovative products including 3D printing sacral plate, 3D printing intervertebral fusion cages, artificial intelligence spine surgery planning system and one startup.


​​​